Regulatory Updates in Brief
This article was originally published in The Gold Sheet
Executive Summary
EU issues GMP Annex 16 on qualified persons; New ISO-9001 standard released; FDA extends comments for “established conditions” guidance; USP to revise General Chapter <797> on pharmaceutical compounding for sterile preparations; and FDA issues guidance on adverse event reporting for 503(b) outsourcing facilities.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.